Furthermore, consistent with the in vitro results, it was also observed that FLZ can be effective for TNBC [28,55,57], showing delayed tumor growth or anti-migration activity, such as a decrease in matrix metalloproteinase-2, and trastuzumab-resistant xenografts in HER2-positive breast cancer [58]. Here, ERBB2 is linked to breast cancer.